Updated: FDA to import more of common cancer drug from China after Indian site closure
The US is planning to import more doses of the chemotherapy cisplatin from China, which is still in short supply after an Indian site voluntarily shut down after quality problems were highlighted by FDA inspectors late last year.
A spokesperson for Apotex, a generic medicine company that is distributing the Chinese-made drug in the US, said that the company is expecting 10 more batches of a version of cisplatin manufactured by Qilu Pharmaceutical, which will arrive for distribution from China later this week.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.